Skip to main content
Caplight Logo









Aimmed

Aimmed

Private
SeoulHealthcare & Life Scienceshttps://aimmed.co.kr/

Last Round

Corporate Funding

Dec 16, 2022

Total Funding Raised

$17.55M

Company Overview

Aimmed is a digital healthcare company that develops digital therapeutics and operates integrated health management platforms for insurance, corporate, and senior care services.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, InsurTech, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

digital therapeuticsDTxsoftware as a medical deviceSaMDcognitive behavioral therapyCBTinsomnia treatmentdigital healthcorporate wellnessemployee assistance programEAPhealth management platforminsurtechpersonalized medicinedigital biomarkersmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aimmed Comparables

Compare Aimmed with similar companies based on industry and business-model similarity.

Aimmed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WELT Corp.
88%
HelloBetter
80%
HAII
77%

Aimmed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingDec 16, 2022
Series AOct 7, 2021

Aimmed Investors

Notable investors and investment history

Aimmed investors
InvestorRounds
TS InvestmentSeries A
Hanwha Asset ManagementSeries A
Korea Investment Private EquitySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 73% MoM to 53.9K.

  • Oct 7, 2021

    $15.2M round with Hanwha Asset Management and others.

Aimmed Filings

Explore SEC and related filing metadata, where available.

Aimmed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aimmed's valuation, stock price, and market status.

Is Aimmed a public or private company?

Aimmed is a private company.

What is the current stock price of Aimmed?

Aimmed is a private company with no public stock price. No recent secondary market data is available.

How much is Aimmed worth (valuation)?

Valuation information for Aimmed is not publicly available.

Can I buy Aimmed stock?

Aimmed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aimmed's last funding round?

Aimmed's most recent funding round was Corporate Funding on December 16, 2022.

Who are the main investors in Aimmed?

Key investors in Aimmed include TS Investment, Hanwha Asset Management, Korea Investment Private Equity.

Will Aimmed IPO soon?

No public IPO plans have been announced for Aimmed.

How can I track Aimmed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aimmed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range38
Year Founded1999
Last FundingDec 16, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?